Physician profile
Bing Chen
NPI 1750876892
$14,572.89
in general payments reported to CMS, 2019-2025
10 companies · $13K in 2025
The $13K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $479 · 2023: $1,005 · 2024: $430 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $13,300.00 |
| Food and Beverage | $794.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,808.82 | 2022-2025 | General - Therapies |
| Cook Incorporated | $800.00 | 2023 | |
| Medtronic, INC. | $333.14 | 2022-2025 | Manoscan, Het, Signia |
| Abbvie INC. | $321.09 | 2022-2024 | Skyrizi, Rinvoq |
| Endogastric Solutions, INC | $121.35 | 2022 | |
| Genzyme Corporation | $94.37 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.43 | 2024 | Eohilia |
| Steris Corporation | $23.26 | 2025 | |
| Ardelyx, INC. | $20.10 | 2024 | Ibsrela |
| Micro-Tech Endoscopy USA, INC. | $16.33 | 2025 | Ensure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bing Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.